Founded in Vancouver in 2008 by aesthetic medicine physician Dr. Robert Morrell, Di Morelli Medical Grade Skin Care built its reputation on translating clinical ingredient technology into simplified daily routines. The brand's two latest launches — the 'Exosome Skin Repair Serum' and the 'Vitamin C Serum for Face and Eye' — continue that approach, bringing regenerative and antioxidant science into accessible at-home formats.
The 'Exosome Skin Repair Serum' ($82 CAD) pairs plant-based exosome technology with ceramides and hyaluronic acid to support barrier health and hydration, with 91% of participants in a brand-conducted study reporting an instant visible improvement in radiance. The 'Vitamin C Serum for Face and Eye' ($99 CAD) uses ascorbyl glucoside, a stabilized vitamin C derivative, alongside palmitoyl oligopeptide and glycerin to target uneven tone, dullness, and early signs of skin fatigue across both the face and delicate eye area. Both serums are designed to integrate into existing routines without added complexity.
What's Driving This Trend
- Clinical-grade Ingredients At-home
- Consumer preference for physician-developed, clinic-strength actives in everyday routines is creating room for affordable, study-backed home-use therapeutics that blur lines between medical and retail products.
- Plant-based Exosome Adoption
- The incorporation of plant-derived exosomes into formulations points to a shift toward bioactive, non-animal regenerative modalities that can enable scalable, sustainability-focused ingredient platforms.
- Dual-purpose Face-and-eye Formulations
- Formulations that safely address both face and delicate eye areas reflect a demand for streamlined regimens and multifunctional products that reduce SKU complexity while maintaining clinical performance.
Who This Affects Most
- Skincare and Beauty
- Bridging clinical efficacy with consumer-friendly formats is driving opportunities for brands to differentiate through validated claims, simplified regimens, and premium positioning at accessible price points.
- Medical Aesthetics
- Physician-founded lines and clinical ingredient translations create possibilities for clinics to offer home-extension therapeutics that complement in-office procedures and extend treatment outcomes.
- Ingredient Biotechnology
- Advances in stabilized vitamin derivatives and plant-based exosome technologies suggest potential for ingredient suppliers to develop novel, patentable bioactives focused on safety, stability, and scalable manufacturing.
